PetVivo Holdings, Inc. (PETV) stock
PETVOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.75+0.00 (0.00%)
Close on Oct 19, 2026Market cap $27.79MP/E –Yield –
PetVivo ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
PetVivo's ebitda for the twelve months ending Jun 30, 2026 was -$8.30M. For fiscal 2026 it was -$8.55M. The highest annual figure on record is -$1.46M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$8.55M | – |
| FY2025 | Mar 31, 2025 | -$7.88M | – |
| FY2024 | Mar 31, 2024 | -$10.49M | – |
| FY2023 | Mar 31, 2023 | -$8.62M | – |
| FY2022 | Mar 31, 2022 | -$4.99M | – |
| FY2021 | Mar 31, 2021 | -$1.87M | – |
| FY2020 | Mar 31, 2020 | -$1.46M | – |
| FY2019 | Mar 31, 2019 | -$4.03M | – |
| FY2018 | Mar 31, 2018 | -$1.64M | – |
| FY2017 | Mar 31, 2017 | -$15.64M | – |
| FY2016 | Mar 31, 2016 | -$2.51M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$1.47M | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$2.83M | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$2.06M | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$1.94M | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$1.73M | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$2.00M | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$1.73M | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$2.14M | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$2.01M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$2.62M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$2.10M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$2.91M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$2.86M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$2.31M | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$2.29M | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$2.09M | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$1.94M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$1.76M | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$1.64M | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$1.09M | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$504.92K | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$299.31K | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$372.99K | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$809.71K | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$390.26K | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$383.35K | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$435.04K | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$288.57K | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$349.63K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$1.13M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$397.03K | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | -$565.97K | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$1.94M | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$795.93K | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | -$373.16K | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | -$151.84K | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | -$321.00K | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | -$513.31K | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | -$334.55K | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | -$14.52M | – |
See a number that looks wrong?